| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |